AMED Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into AMED


Also see:
AMED stock yearly return 2014
AMED stock yearly return 2015
AMED stock yearly return 2016
AMED stock yearly return 2017
AMED stock yearly return 2018
AMED stock yearly return 2019
AMED stock yearly return 2020
AMED stock yearly return 2021
AMED stock yearly return 2022
AMED stock yearly return 2023
AMED YTD return
Compare AMED average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 03/31/2014
End date: 03/28/2024
Start price/share: $14.89
End price/share: $92.16
Dividends collected/share: $0.00
Total return: 518.94%
AMED Average Annual Return: 20.00%
Starting investment: $10,000.00
Ending investment: $61,917.36
Years: 10.00


AMED average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Amedisys is a healthcare services company. Co.'s four reportable business segments are: home health, hospice, personal care and high acuity care. Co.'s home health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with tasks. Co.'s hospice segment provides palliative care and comfort to terminally ill patients and their families. Co.'s personal care segment provides patients with assistance with the essential activities of daily living. Co.'s high acuity care segment delivers the elements of inpatient hospital and skilled nursing facility care to patients in their homes. The AMED average annual return 10 years is shown above.

The Average Annual Return on the AMED average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether AMED average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the AMED average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree AMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amedisys (AMED) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

AMGN Average Annual Return
AMLX Average Annual Return
AMN Average Annual Return
AMPH Average Annual Return
AMRX Average Annual Return
ANAB Average Annual Return
ANEB Average Annual Return
ANGO Average Annual Return
ANIK Average Annual Return
ANIP Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Amedisys (AMED) ranks in the top 25% of all stocks whose returns we have reviewed.
What has the average annual return been for AMED over the past ten years?
✔️Accepted answer: The ten year AMED average annual return has been 20.00%.

What start date was used in your AMED average annual return calculation?
✔️Accepted answer: The start date was 03/31/2014.

What end date was used in your AMED average annual return calculation?
✔️Accepted answer: The end date was 03/28/2024.

If I had invested $10,000 into AMED ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 03/28/2024, you would have $61,917.36.

What does that work out to on a total return basis?
✔️Accepted answer: The AMED ten year total return ending 03/28/2024 works out to 518.94%.


Also see:
AMED stock yearly return 2014
AMED stock yearly return 2015
AMED stock yearly return 2016
AMED stock yearly return 2017
AMED stock yearly return 2018
AMED stock yearly return 2019
AMED stock yearly return 2020
AMED stock yearly return 2021
AMED stock yearly return 2022
AMED stock yearly return 2023
AMED YTD return
 

AMED Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.